Zuellig, “Novartis is only former minority shareholder which already transferred shares back to us”
Zuellig Pharma Korea announced an official position about its relationship with Novartis, which was indicated at the Ministry of Health and Welfare’s National Inspection.
On the 29th, Zuellig announced “We found untruthful information over several issues indicated by Assemblyperson Hye-Sook Jeo...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
